Showing results (201-210 of 241) with videos related to
Sort By:
Pageof 25
British Journal of Cancer|September 1, 1981
Application of monoclonal antibodies to purified CEA in clinical radioimmunoassay of human serumG T Rogers, G A Rawlins, P A Keep, et al.European Journal of Haematology. Supplementum|January 1, 1989
Renal failure in myelomatosisI C MacLennan, E H Cooper, C E Chapman, et al.British Journal of Cancer|December 1, 1985
Urinary pseudouridine excretion in myelomatosisS H Sørensen, D A Brown, E H Cooper, et al.Clinical Chemistry|March 1, 1994
Commercial assays for serum osteocalcin give clinically discordant resultsP W Masters, R G Jones, D A Purves, et al.British Journal of Cancer|September 1, 1994
The role of CA-242 and CEA in surveillance following curative resection for colorectal cancerN R Hall, P J Finan, B M Stephenson, et al.European Urology|January 1, 1983
Monitoring of prostatic cancer by an enzyme-linked immunosorbent assay of serum prostatic acid phosphataseE H Cooper, N B Pidcock, D Daponte, et al.Medical and Pediatric Oncology|January 1, 1977
Cancer markers in patients receiving chemotherapy for colorectal cancer: a preliminary reportB R Bullen, E H Cooper, R Turner, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1984
The prognostic significance of acute phase proteins in patients with inoperable squamous cell carcinoma of the bronchusR J Caspers, N B Pidcock, E H Cooper, et al.Diabetes Research (Edinburgh, Scotland)|May 1, 1986
Low molecular weight proteinuria in insulin-dependent diabetesJ A Fletcher, R A Crockson, C Mijovic, et al.Gynecologic Oncology|October 1, 1983
Biochemical aids in the monitoring of patients with ovarian cancerJ H Meerwaldt, W G Haije, E H Cooper, et al.Pageof 25